Skip to main content
. Author manuscript; available in PMC: 2009 Aug 27.
Published in final edited form as: Pharmacogenet Genomics. 2009 Feb;19(2):161–169. doi: 10.1097/FPC.0b013e32831e030e

Table 5.

Association of APOA1/C3/A4/A5 common haplotypes with lipid response to fenofibratea

Haplotype–genotype mean (SE)
for TG response
Haplotype–genotype mean (SE)
for HDL cholesterol response
Haplotypeb Haplotype
frequency
+ / + c ± d − / − e Haplotype
P
Global
P
+ / + c ± d − / − e Haplotype
P
Global
P
Hap1 CAAACGGCCA 0.462 − 1.995 (0.211) − 2.293 (0.149) − 2.113 (0.207) 0.429 0.003* 0.112 (0.008) 0.128 (0.007) 0.132 (0.007) 0.202 0.014
Hap2 CAAACTGCCA 0.071 − 0.743 (0.167) − 1.851 (0.186) − 2.230 (0.134) < 0.0001* 0.113 (0.005) 0.111 (0.010) 0.128 (0.004) 0.031
Hap3 CAAACGGTCG 0.067 − 0.256 (0.999) − 1.773 (0.333) − 2.238 (0.137) 0.035 0.123 (0.046) 0.126 (0.015) 0.126 (0.004) 0.997
Hap4 CAAAGTACCG 0.048 − 1.172 (0.476) − 2.476 (0.315) − 2.150 (0.131) 0.077 0.052 (0.022) 0.121 (0.017) 0.126 (0.004) 0.011
Hap5 CGGGCTATGG 0.044 − 1.052 (0.162) − 2.136 (0.121) − 2.732 (0.508) < 0.0001* 0.077 (0.006) 0.143 (0.015) 0.125 (0.004) < .0001*
Hap6 GAAACGGTCG 0.044 − 4.940 (1.818) − 3.951 (1.731) − 2.088 (0.108) 0.231 0.159 (0.032) 0.195 (0.026) 0.123 (0.004) 0.032

HDL, high-density lipoprotein; TG, triglyceride.

a

Response to fenofibrate (phenotype) was represented by slope estimate from growth curve models.

b

Haplotypes were determined using the Haploview software for tag SNPs following the order of APOA5_S19W, APOA5_M1123, APOA4_N147S, APOA4_T29T, APOA4_M35, APOC3_M640, APOC3_M482, APOC3_G34G, APOC3_3U386, and APOA1_M2803. To maximize the statistical power, we only tested associations for the haplotypes with estimated frequencies greater than 0.04.

c

Two copies of the haplotype of interest.

d

One copy of the haplotype of interest.

e

Any other haplotype combination.

*

P < 0.05 are shown in boldface; indicates significant associations after Bonferroni’s correction. The significance threshold is P < 0.008 (0.05/6).